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Cesarean sectionAbstract Background: Cesarean section is considered as one of the most commonly done surgical
procedures, which have a rising rate of performance. Postoperative pain may lead to poor patient
satisfaction and interfere with early rehabilitation. Increasing evidence is now suggesting that less
invasive regional analgesic techniques may be as beneficial as epidural analgesia. This study aimed
to compare efficacy, safety and side effect of bupivacaine continuous wound infusion using constant
flow PainFusor system with epidural infusion for post-cesarean section analgesia.
Methods: 60 patients, ASA physical status I & II, aged 19–42 years, with full-term pregnancy
undergoing elective cesarean section were randomly divided into two groups. All patients enrolled
in the study performed cesarean section under standardized protocol of general anesthesia. Group
A patients received continuous surgical wound infiltration, while group B patients received bupiva-
caine continuous epidural infusion. Pain was assessed using Visual analogue scale (VAS). Diclofe-
nac sodium 75 mg was administered IM as a rescue analgesic.
Results: The current study showed no significant difference between the two groups in the hemo-
dynamic parameters, respiratory parameters as well as pain scores at rest during the whole period of
study. Side effects were statistically non-significant, and only patients who requested analgesia were
significantly higher in group A. Furthermore, pain VAS scores on mobilization were significantly
lower in group B during the first postoperative day.
Conclusion: The current study demonstrated that bupivacaine administered by continuous epidural
infusion provided a significantly lower pain scores with mobilization, and hence better analgesia for
post cesarean section pain in the first postoperative day compared to continuous bupivacaine
wound infusion through fenestrated catheter using the constant flow PainFusor system.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Effective management of postoperative pain is a patient right
and essential requirement to minimize stress response follow-
ing surgical intervention [1]. Obstetric patients differ from
other surgical patient population due to the increased concerns
about postoperative pain as well as the need for early patient
mobilization besides newborn care and nursing [2]. Cesarean
section (CS) is considered as one of the most commonly done
surgical procedures, which have a progressively rising rate of
performance. Being associated with intense and severe postop-
erative pain, CS pain may lead to poor patient satisfaction and
interfere with early rehabilitation and movement in addition to
improper or delayed newborn care [2]. Epidural analgesia is
considered as the most effective technique for postoperative
pain control in abdominal surgery. Its use as an effective
modality for pain relief following major surgery via local anes-
thetic and opioids, bolus or infusion, started as early as 1980s
[3]. However when using regional anesthesia, anesthesiologist
may have to use certain neuraxial medications e.g. intrathecal
or epidural opioids which beside improving the analgesia is
associated with higher risk of side effects such as pruritus,
urine retention, constipation and nausea and vomiting [4].
Recently, evidence-based data suggested that the benefits of
the epidural analgesia are not as significant as it was previously
thought. Although it has benefits in deceasing cardiothoracic
and pulmonary complications especially in high risk patients
who undergo major abdominal or thoracic surgery, yet
increasing evidence is now suggesting that less invasive regio-
nal techniques for analgesia e.g. paravertebral, femoral, or sci-
atic blocks may be as beneficial as epidural analgesia [5].
Furthermore, surgical wound infusion techniques are sug-
gested as a safe and simple alternative to epidural in various
surgical procedures [5].
Infiltration of the surgical wound with local anesthetic
has been widely described and used for multimodal pain
management [6]. A systemic review of randomized controlled
trials of surgical wound infiltration emphasized the safety
and advantages of this technique with reduction in opioid
consumption, and hence opioid side effects [7]. Single bolus
local anesthetic wound infiltration has been used in a wide
range of surgeries including thoracic, abdominal, cardiac
or pelvic procedures, yet its efficacy and duration of action
were much lower than continuous surgical wound infiltration
with local anesthetic through a fenestrated catheter placed
above or below the muscle sheath by the surgeon at the site
of surgical incision [8,9]. Several recommendations of well
designed, large sampled, homogenous RCT were made, sug-
gesting that such studies are valuable to optimize outcomes,
and to assess the effect of continuous wound infusion on the
length of hospital stay and cost effectiveness in ambulatory
surgery [10].
The objective of this randomized, controlled study was to
compare the efficacy and side effects of bupivacaine continu-
ous surgical wound infusion (BCWI) using a fenestrated cathe-
ter connected to a constant flow PainFusor system, with
continuous epidural infusion, in controlling postoperative pain
following CS in the first 24 h postoperatively. Our hypothesis
was that wound infusion may offer better postoperative pain
relief.2. Patients and methods
After obtaining approval from the Clinical Research Ethics
Committee of Erfan and Bagedo General Hospital and obtain-
ing written informed consent, the study was conducted. Sixty
patients, (ASA) physical status I & II, aged 19–42 years, with
full-term pregnancy (37–40 weeks gestational age), body mass
index ranging from 20.0 to 30.0 kg/m2, undergoing elective
cesarean section were enrolled in the current study. The
patients were randomly divided, using computer-conducted
concealed envelope method, into two equal groups: patients
in group A (n= 30) received continuous surgical wound infil-
tration with bupivacaine 0.25% while Group B (n= 30)
patients received continuous epidural infusion with bupiva-
caine 0.125% and fentanyl. Inclusion criteria were ability to
consent; and ability to understand and communicate (the
absence of language barrier). Exclusion criteria were cardio-
vascular, hepatic or renal dysfunction, coagulation disorders
or anticoagulant therapy, neuromuscular diseases, opioid or
analgesic abuse, alcohol abuse, allergy to any of the used drugs
and history of chronic pain syndrome or drug addiction.
The linear visual analogue scale (VAS) for assessment of
pain, which is a 10 cm linear scale where zero is no pain and
ten is the worst imaginable pain, was explained to all patients
in both groups of the study before surgery starts. Patients were
asked to locate their pain on this linear scale. All surgical pro-
cedures were performed by the same surgeon. All patients after
admission to operating theater were placed in sitting position;
the back was sterilized, and local anesthesia given. Then an 18
gauge Tuohy needle was used to insert epidural catheter using
loss of resistance to air technique through midline approach at
the level of L3-4 vertebrae. 10 ml of normal saline was injected
to ensure catheter patency. All patients enrolled in the study
performed CS under standardized protocol of general anesthe-
sia, where only ondansetron 0.1 mg/kg was given as the sole
premedication and induction was done using propofol 2 mg/
kg and succinylcholine 1 mg/kg followed by atracurium
0.5 mg/kg, and maintained using sevoflurane with 50% nitrous
oxide in oxygen, and after delivery of the baby fentanyl 100 lg
was given. In both groups, after closure of the peritoneum the
surgeon was asked to puncture the skin 2–3 cm lateral to the
end of the skin incision and pass a 15 cm long fenestrated
catheter (Baxter PAINfusor catheter 15; Baxter Healthcare
S.A., Zurich, Switzerland) placing it pre-peritoneal under the
fascia such that the fenestrations are available along the whole
wound length. The catheter was then taped and fixed to the
skin to prevent its slipping out or changing position during
the rest of the surgical procedure. 10 ml normal saline was
injected through the catheter to confirm its patency.
Following the end of surgery, and immediately after patient
extubation, in group A: bupivacaine 0.25% infusion was
started at a rate of 10 ml/h in the abdominal catheter using
the constant infusing PainFusor system (Baxter LV5 INfusor
and PAINfusor; Baxter Healthcare International Inc, Deer-
field, IL 60015 USA) and epidural infusion was started with
normal saline as a placebo at the same rate as in the other
group. On the other hand in group B: normal saline was con-
nected to the catheter as a placebo simulating group A and
epidural infusion of bupivacaine 0.125% with fentanyl 2 lg/
ml was started at a rate of 10 ml/h. Infusions were continued
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1 g Paracetamol every 12 h intravenously in the first 48 postop-
erative hours. In case of breakthrough pain, if the VAS
recorded increased more than 5, Diclofenac sodium 75 mg
was administered intramuscular (IM) as a rescue analgesic.
Moreover, in case of: bradycardia less than 50 BPM, oxygen
saturation less than 90%, bradypnea less than 8 breath/min,
sedation P2, or hypotension less than 90/60 mmHg the infu-
sions were stopped and these parameters were assessed every
five minutes till they return to normal and then the infusions
were restarted. Patients were monitored all through the study.
All medications and intravenous solutions were prepared in
the pharmacy outside the operating theater and sent to the
anesthesiologist as apparently identical infusions with a prede-
termined rate; in addition, patients as well as the anesthesiolo-
gist and the surgeon were blinded to the type of the
medications infused and the master codes were kept with a per-
son that does not share in the collection or analysis of the
results.
The Primary and secondary outcomes were assessed at 1, 6,
12, and 24 h postoperatively and then a follow-up reading at
48 h was recorded. Primary outcome variables of the study
were the presence of VAS > 5 indicating unbearable pain at
rest or on mobilization (whether coughing or ambulation),
during the first 24 h after surgery, whereas secondary outcome
variables included hemodynamic parameters (namely systolic
blood pressure (SBP), diastolic blood pressure (DBP), and
heart rate (HR)), respiratory parameters (namely respiratory
rate ‘RR’ and oxygen saturation ‘Spo2’), number of patients
requested rescue analgesic, in addition to incidence and degree
of sedation as evaluated by a 5-point rating scale such that 0 isGroup A 
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(n=29)
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Figure 1 The patient selection, allocatfully awake, 1 is drowsy but responding to verbal commands, 2
is sedated but easily aroused by light touch, 3 is sleepy but
aroused by painful stimulus, and 4 is deeply sedated, not
arousable. Other complications including incidence of postop-
erative nausea and vomiting (PONV) and the need for antie-
metic medications, pruritus, hypotension, bradycardia, low
oxygen saturation as well as urine retention were also
recorded.
Data were analyzed using computer statistical software sys-
tem SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).
Descriptive data were expressed as mean (±SD) or number
(proportion) as appropriate. Patient demographic data and
rescue analgesia administered were analyzed and compared
using Student’s t-test and Fisher’s exact test, whereas differ-
ences between the groups in pain scores were analyzed and
compared using Mann-Whitney U test, and Bonferroni cor-
rection was performed because of the presence of repeated
measures. Sample size was calculated using Power Analysis
and Sample Size 14.0 software PASS (NCSS, Kaysville, UT,
USA). It was estimated using pain scores as the primary
variable. Assuming pain score difference of 2 ± 2 standard
deviation (SD), a priori sample size analysis was done and
calculated to be 56 patients (28 per group) would be sufficient
to detect a difference on the VAS with a= 0.05 (two tailed)
and 90% power. However, 30 patients were enrolled in each
group to ensure adequate power and allow for possible
drop-outs. The incidence of complications as pruritus, PONV,
urine retention was analyzed and compared using Fisher’s
exact test. P-value less than 0.05 was considered statistically
significant except for pain scores when Bonferroni correction
was used, where a P-value less than 0.01 was considered toGroup B 
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3. Results
60 patients were assessed for eligibility for the current study all
of which were enrolled in the study and were randomly classi-
fied into two equal groups. All patients of group B succeeded
to complete the study, while in group A one patient failed to
complete the study because the catheter was blocked after
8 h postoperatively and was excluded from the study
(Fig. 1). The current study showed no differences in demo-
graphic data including age, body weight or body mass index
(BMI) between group A and group B as seen in Table 1.
The mean duration of the CS procedure was comparable in
both groups (Table 1).
Similar to demographic data, the hemodynamic parameters
such as systolic blood pressure (SBP), diastolic blood pressure
(DBP), and heart rate (HR) in the current study showed no
significant difference in the values measured among both
groups as shown in Table 2. Furthermore, no significant differ-
ence was detected between the groups regarding respiratory
parameters namely respiratory rate (16.4 ± 2.0 breath/min)
for group A versus (17.1 ± 1.8 breath/min) for group B
(P = 0.16), and oxygen saturation of 98.23 ± 0.1 versus
98.30 ± 0.3 for groups A and B respectively (P= 0.23).Table 1 Demographic characteristics and operative data of
patients receiving bupivacaine wound infusion (group A) and
bupivacaine epidural analgesia (group B). Values are expressed
as mean (SD).
Group A Group B P Value
(n= 29) (n= 30)
Age; years 28.9(1.7) 29.4(1.2)
Body weight; kg 65(22) 66(16)
BMI; kg/m2a 27.8(0.2) 26.9(0.8)
Duration of surgery; min 63.4(29) 71.1(19) 0.2
No significant differences between the two groups.
a BMI = Body mass index.
Table 2 Postoperative hemodynamic parameters (secondary outco
and bupivacaine epidural analgesia (group B) following cesarean sec
SBP (mmHg)a DBP (mm
Group A Group B Group A
(n= 29) (n= 30) (n= 29)
1 h 130 (6) 126 (2) 75 (4)
6 h 128 (7) 123 (5) 76 (3)
12 h 132 (2) 124 (3) 73 (5)
24 h 131 (4) 120 (4) 75 (6)
48 h 127 (6) 121 (2) 72 (8)
No significant differences between the two groups (P value > 0.05).
a SBP = systolic blood pressure.
b DBP= diastolic blood pressure.
c HR= heart rate.Regarding pain scores as evaluated by VAS, no significant
difference was detected between the two groups in pain scores
at rest during the whole period of study at 1, 6, 12, or 24 h
(Fig. 2). However, at 6 h the VAS scores on mobilization were
significantly lower in group B compared to group A
(P< 0.001) with a confidence interval (95% CI 0.1–0.2) as
shown in Fig. 3. Similarly, at 1 and 12 h VAS scores were sig-
nificantly lower in group B, yet the recorded values in group A
decreased to show no statistically significant difference from
group B at 24 (Fig. 3). Regarding the follow-up after 48 h,
no significant difference was detected between the two groups
both at rest and mobilization (Figs. 2 and 3).
As for the other secondary outcome variables, five patients
in group A requested rescue analgesia as shown in Table 3 and
were given Diclofenac which was significantly higher than in
group B where no patients requested analgesia (P= 0.02) with
a confidence interval (95% CI 0.08–0.35). On the contrary,
seven patients in group B suffered from pruritus which were
significantly higher than in group A which showed no pruritus
in any of the group patients (P= 0.006) with an absolute risk
reduction of 0.23 (95% CI 0.8–0.38) (Table 3). Only one
patient in group B showed PONV not necessitating antiemetic
medication, as well as other patient in the same group devel-
oped temporary hypotension which was managed by bolusme) for both bupivacaine continuous wound infusion (group A)
tion. Values expressed as mean (SD).
Hg)b HR (beat/min)c
Group B Group A Group B
(n= 30) (n= 29) (n= 30)
69 (1) 77 (4.3) 72 (1.8)
68 (5) 74 (4.6) 68 (6.4)
65 (4) 79 (6.3) 74 (4.1)
67 (8) 85 (6.4) 73 (6.6)
67 (3) 83 (7.1) 76 (6.2)
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Figure 2 The pain VAS scores at rest at 1, 6, 12, and 24 h
postoperatively (primary outcome) in patients receiving bupiva-
caine wound infusion (group A) or bupivacaine epidural analgesia
(group B). Follow-up VAS reading at 48 h was recorded. Values
expressed as mean ± SD. No significant difference between the
two groups (P value > 0.05).
±0.3 ±0.3
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Figure 3 The pain VAS scores with mobilization at 1, 6, 12, and
24 h postoperatively (primary outcome) in patients receiving
bupivacaine continuous wound infusion (group A) or bupivacaine
epidural analgesia (group B). Follow-up pain score was recorded
at 48 h. Values expressed as mean ± SD. (*) indicate significantly
lower scores at one, six and 12 h in group B (P value < 0.001).
Table 3 Secondary outcome variables and complications of
patients with bupivacaine continuous wound infusion (group
A) and bupivacaine epidural analgesia (group B) following
cesarean section. Values are expressed as number (proportion).
Group A Group B P value
(n= 29) (n= 30)
Patients requested analgesic 5 (17%)* 0 0.02
Pruritus 0 7 (23%)* 0.006
PONVb 0 1 (3.3%) 0.3
Hypotension (<90/50 mmHg) 0 1 (3.3%) 0.3
Bradycardia (<50 beats/min) 0 0
Low oxygen saturation (<90%) 0 0
Sedated patients (P2) 0 0
Urine retention 0 1 (3.3%) 0.3
* Indicates significant difference.
b PONV= postoperative nausea and vomiting.
Bupivacaine constant continuous surgical wound infusion versus continuous epidural infusion 545IV 500 ml of normal saline solution. Furthermore, one patient
in group B developed urine retention necessitating temporary
catheter insertion. None of the patient of the current study
in both groups developed sedation, bradycardia or low oxygen
saturation with no significant difference among the two groups
in these secondary variables as demonstrated in Table 3.
4. Discussion
The results of the present prospective randomized placebo-
controlled study concluded that continuous epidural analgesia
provided lower pain scores indicating superior control of pain
only during patient mobilization in the first postoperative day
following cesarean section more than continuous surgical
wound infusion with local anesthetic using continuous con-
stant PainFusor system. On the other hand, pain at rest,
showed no significant difference between the groups during
the first postoperative day. Follow-up pain scores, at rest or
mobilization, during the second postoperative day were com-
parable. Furthermore, rescue analgesia requirement was signif-
icantly higher during the first day postoperatively in
continuous surgical wound infusion group. However, fewer
complications were seen in bupivacaine wound infusion group
compared to bupivacaine continuous epidural infusion whichshowed a significantly higher incidence of pruritus, as well as
incidence of PONV, urine retention and hypotension. Besides,
no patients in both groups were complicated with postopera-
tive sedation or bradycardia, and the hemodynamic parame-
ters such as HR, SBP and DBP as well as respiratory
parameters RR and Spo2 also showed no significant changes
in both groups. Such results suggested that continuous surgical
wound infusion though may not offer a superior alternative to
continuous epidural infusion with local anesthetic for pain
control in the first postoperative day after elective cesarean
section during mobilization, yet it offered comparable pain
relief at rest.
Consisting of several different components, postoperative
pain associated with cesarean section operation arises mainly
from a visceral component from the uterus and a somatic pari-
etal component from the muscle and cutaneous nociceptors
[11]. For that reason, assumption was done that the placement
of fenestrated catheter in such position improves pain control
being close to the peritoneum and muscle fascia which are rich
in pain nerve endings damaged by the surgical incision [12].
However, several concerns still arouse about the ideal protocol
for using continuous surgical wound infusion for management
of postoperative pain, including the best surgical plane for
catheter application, the type and concentration of the local
anesthetic used, the length of the catheter and number of fen-
estrations, and the flow rate of the local anesthetic whether
constant or changeable [13]. Many clinical trials were done
to identify the best location for the catheter suggesting various
positions including, above the fascia [14,15], intraperitoneal
[16], as well as above and below the fascia [17]. These studies
generally suggested a decrease in the opioid consumption but
with no difference in the overall pain scores at rest or mobility
compared to the control groups. Our choice for the pre-
peritoneal location of the catheter was based on previous stud-
ies [11,18,19] that showed better pain score.
The efficacy, safety and side effects of surgical wound infil-
tration with local anesthetic for postoperative pain relief fol-
lowing cesarean section were evaluated in previous studies
[19,20]. In a study by Ranta et al. [20] the author compared
bupivacaine surgical wound infiltration to epidural analgesia
using repeated bolus doses of local anesthetic in both routes.
They concluded that the incisional infiltration with local anes-
thetic using a sub-fascial catheter provided analgesia compara-
ble to epidural analgesia, yet in the first four postoperative
hours, their study results showed better pain scores with the
epidural analgesia group which supports the results of our
study. On the contrary to the present study, in a later study
done by O’Niell and colleagues [19] comparing continuous
wound infusion with ropivacaine for controlling postoperative
pain following cesarean section with epidural morphine bolus
injections, their conclusion was that wound infusion was easy
and safe and provided better analgesia than epidural morphine
with lower side effects besides being a good choice if epidural
was not possible. We suggest that the conflict between their
pain scores and the current study results can be explained by
the use of continuous epidural infusion in our study instead
of repeated bolus administration, besides the use of epidural
combination of local anesthetic and opioid. Nevertheless, in
a letter to the editor, Bhatia and Sen [21] considered that a
great limitation of that study was the use of single doses, both
ropivacaine and morphine, in both groups suggesting a better
trial with different drug doses for best dose identification.
546 H.A. ELShamaa, M. IbrahimFurthermore, the result of the study by Zohar et al. [14] which
compared surgical wound infiltration using patient controlled
analgesia (PCA) with systemic non-steroidal anti-
inflammatory drugs (NSAID) for post-cesarean section pain,
showed inferior analgesia and lower patient satisfaction in
the wound infiltration group. The author emphasized the
importance of the systemic use of adjuvant NSAID for postop-
erative pain management, a result that was consistent with the
recorded pain scores in the current study. Moreover, in a study
by Dowidar and colleagues [22] who compared postoperative
analgesia using continuous wound infusion with that using rec-
tus sheath catheter, they concluded that ultrasound guided rec-
tus sheath catheter provided superior analgesia with a
significantly lower VAS, heart rate and blood pressure com-
pared to continuous surgical wound infusion. Going with the
present study, the VAS in their study was significantly higher
with movement in the continuous wound infusion group. In
addition, Kainu et al. [23] concluded in their study that ropiva-
caine continuous wound infusion fails to decrease the oxy-
codone PCA as well as pain scores compared to intrathecal
morphine in post-cesarean section pain management.
There are some limitations for our current study including
the use of plain bupivacaine continuous wound infusion,
whereas using additives e.g. opioids may result in better anal-
gesic outcome. In addition, the use of a changing flow PainFu-
sor system might have resulted in better pain scores. Moreover,
another limitation to the current study was that the outcome
analgesia in wound infusion technique is dependent on proper
catheter position with the fenestration available along the
whole length of the wound. Furthermore, the undetermined
optimal local anesthetic concentration, type and flow rate are
also considered as further limitations for the study.
In conclusion, although continuous surgical wound infu-
sion with local anesthetic is a safe, easy and simple technique
for postoperative analgesia, yet continuous epidural analgesia
provided superior pain control during mobilization in the first
postoperative day. The present study demonstrated that con-
tinuous epidural infusion with bupivacaine 0.125% and fen-
tanyl 2 l/ml at a rate of 10 ml/h provided a significantly
better analgesia and lower pain score for post cesarean section
pain during mobilization in the first postoperative day com-
pared to bupivacaine 0.25% continuous wound infusion at
rate of 10 ml/h through fenestrated catheter using the constant
flow PainFusor system. However, pain relief at rest was com-
parable. Moreover, higher incidence of side effects was
reported with epidural analgesia rather than wound infusion.
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